Deep Learning Unlocks Valuable Cancer Biology Clues
Dana-Farber Cancer Institute
AI models uncover patterns across two-dimensional images of tumor samples that could help predict response to immunotherapy
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers
ADLM guidance shares tools and strategies to achieve bias-free patient care